M1 Kliniken AG (DE:M12)
XETRA:M12
Want to see DE:M12 full AI Analyst Report?
Top Page
M1 Kliniken AG
(XETRA:M12)
Select Model
Select Model
Rating:83Outperform
Price Target:
€22.00
▲(21.15% Upside)
Action:Reiterated
Date:05/25/26
The score is driven primarily by strong financial performance (improving earnings, low leverage, and solid recent cash generation) and an attractive valuation (low P/E with a dividend). Technicals are supportive with price above major moving averages and positive MACD, though momentum indicators are somewhat elevated.
Positive Factors
Consistent Revenue Growth
Multi-year revenue growth through 2025 demonstrates persistent demand for the company’s elective services and expanding clinic activity. Sustained top-line expansion supports scale economics, predictable cash generation, and the ability to invest in higher-margin procedures and capacity over the next several months.
Negative Factors
Margin Volatility and Limited 2025 Detail
Historical swings in gross and net margins suggest profitability depends on procedure mix, supplier terms, and pricing power. Absence of detailed 2025 margin breakdown limits confidence in whether recent margin improvements are structural, increasing earnings predictability risk over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Multi-year revenue growth through 2025 demonstrates persistent demand for the company’s elective services and expanding clinic activity. Sustained top-line expansion supports scale economics, predictable cash generation, and the ability to invest in higher-margin procedures and capacity over the next several months.
Read all positive factors
M1 Kliniken AG (M12) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€332.10M
Dividend Yield2.8%
Average Volume (3M)13.86K
Price to Earnings (P/E)14.6
Beta (1Y)0.32
Revenue Growth7.40%
EPS Growth38.17%
CountryDE
Employees219
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.20
Shares Outstanding19,643,402
10 Day Avg. Volume17,849
30 Day Avg. Volume13,861
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)2.94
Price to Sales (P/S)0.97
P/FCF Ratio9.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.04
Revenue Forecast (FY)€134.38M
M1 Kliniken AG Business Overview & Revenue Model
Company Description
M1 Kliniken AG, a Berlin, Germany-based entity established in 2007 and operating as a subsidiary of MPH Health Care AG, manages medical facilities dedicated to aesthetic and plastic surgery across Germany, Austria, the Netherlands, Switzerland, th...
How the Company Makes Money
M1 Kliniken AG generates revenue mainly through patient-paid medical services delivered in its own clinic network. This includes consultation fees and the provision of elective aesthetic treatments and procedures (e.g., minimally invasive aestheti...
M1 Kliniken AG Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
82
Very Positive
| Breakdown | Dec 2025 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 364.30M | 339.18M | 316.32M | 285.29M | 314.61M |
| Gross Profit | 47.43M | 63.60M | 32.47M | 21.72M | 26.06M |
| EBITDA | 40.49M | 33.44M | 21.79M | 16.07M | 19.78M |
| Net Income | 22.13M | 16.02M | 10.27M | 4.32M | 8.91M |
Balance Sheet | |||||
| Total Assets | 189.29M | 187.87M | 212.95M | 197.02M | 198.11M |
| Cash, Cash Equivalents and Short-Term Investments | 42.00M | 23.69M | 22.76M | 47.50M | 49.12M |
| Total Debt | 10.26M | 10.42M | 17.04M | 19.67M | 30.93M |
| Total Liabilities | 39.28M | 53.65M | 69.73M | 53.97M | 58.21M |
| Stockholders Equity | 119.93M | 106.10M | 113.25M | 95.52M | 95.03M |
Cash Flow | |||||
| Free Cash Flow | 37.84M | 29.55M | 6.80M | 19.25M | 14.32M |
| Operating Cash Flow | 33.80M | 30.55M | 7.81M | 21.02M | 15.66M |
| Investing Cash Flow | -645.81K | -5.67M | -9.36M | -1.77M | 213.19K |
| Financing Cash Flow | -13.41M | -30.44M | -14.81M | -21.97M | 4.03M |
M1 Kliniken AG Technical Analysis
Neutral
18.16
Price Trends
17.24
Positive
16.66
Positive
16.23
Positive
Market Momentum
0.09
Positive
43.51
Neutral
18.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:M12, the sentiment is Neutral. The current price of 18.16 is below the 20-day moving average (MA) of 18.64, above the 50-day MA of 17.24, and above the 200-day MA of 16.23, indicating a neutral trend. The MACD of 0.09 indicates Positive momentum. The RSI at 43.51 is Neutral, neither overbought nor oversold. The STOCH value of 18.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:M12.
M1 Kliniken AG Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | €332.10M | 14.64 | 18.60% | 2.80% | 7.40% | 38.17% | |
74 Outperform | €159.00M | 26.68 | 24.05% | ― | 33.49% | 81.79% | |
72 Outperform | €117.74M | 4.05 | 12.13% | 5.31% | -41.04% | -191.53% | |
63 Neutral | €189.05M | 7.01 | 11.90% | 1.12% | 5.13% | 11.89% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | €18.98M | -1.16 | 23.56% | ― | 3.51% | -5.66% |
* Healthcare Sector Average
DE:M12
M1 Kliniken AG
17.46
3.34
23.65%
DE:MED
MEDICLIN
4.06
1.13
38.66%
DE:MAK
MATERNUS-Kliniken AG
0.89
-0.59
-39.80%
DE:LIK
Limes Schlosskliniken AG
510.00
158.00
44.89%
DE:HAEK
HAEMATO AG
12.90
2.44
23.33%
DE:93M1
MPH Health Care AG
27.70
9.38
51.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.